Women who develop heavier placentas during pregnancy have a higher risk of breast cancer, according to the results of a population-based cohort study from Sweden.
Women who develop heavier placentas during pregnancy have a higher risk of breast cancer, according to the results of a population-based cohort study from Sweden.
Researchers looked at how a number of pregnancy characteristics influenced the risk of breast cancer in a cohort of over 300,000 women. They found that compared with women whose placentas weighed less than 500 g in two consecutive pregnancies, the risk of breast cancer was almost doubled (adjusted hazard ratio, 1.82) in women whose placentas weighed between 500 and 699 g in their first pregnancy and at least 700 g in their second pregnancy (or vice versa) and was slightly more than doubled (adjusted hazard ratio, 2.05) in women whose placentas weighed at least 700 g in both pregnancies.
Other first-birth factors found to be associated with a higher risk of maternal breast cancer included delivering an infant weighing 4,500 g or more, delivering at 42 weeks or later, greater maternal age, and greater maternal height. Women with body mass indices of 29 or higher and women who smoked during pregnancy had lower rates of breast cancer than counterparts.
Cnattingius S, Torrang A, Ekbom A, et al. Pregnancy characteristics and maternal risk of breast cancer. JAMA. 2005;294:2474-2480.
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More
Study finds reduced CIN3+ risk from early HPV vaccination
April 16th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
Read More